APERAM S.A. NY SHS/1 O.N. Cash Flow-to-Debt Ratio
APERAM S.A. NY SHS/1 O.N. cash flow-to-debt ratio. APERAM S.A. NY SHS/1 O.N. (7AAN) has a Cash Flow-to-Debt Ratio of 0.04x as of June 2026, meaning its operating cash flow of €139.00 Million could theoretically repay 0% of its total liabilities (€3.49 Billion) in one year. Check 7AAN cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of APERAM S.A. NY SHS/1 O.N. (2022–2025)
Cash flow-to-debt ratio of APERAM S.A. NY SHS/1 O.N. from 2022 to 2025. Historical debt coverage capacity for APERAM S.A. NY SHS/1 O.N. across 4 annual periods. Check 7AAN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
APERAM S.A. NY SHS/1 O.N. Cash Flow-to-Debt Ratio by Year (2022–2025)
APERAM S.A. NY SHS/1 O.N. cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for APERAM S.A. NY SHS/1 O.N.. For the full cash flow conversion analysis, see APERAM S.A. NY SHS/1 O.N. (7AAN) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | €422.00 Million | €1.97 Billion | ▲ +89.8% |
| 2024 | 0.11x | €280.00 Million | €2.47 Billion | ▼ -33.6% |
| 2023 | 0.17x | €471.00 Million | €2.76 Billion | ▼ -24.0% |
| 2022 | 0.22x | €642.00 Million | €2.87 Billion | — |